105
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Voriconazole is a broad-spectrum triazole that is active against aspergillus species. We conducted a randomized trial to compare voriconazole with amphotericin B for primary therapy of invasive aspergillosis.

          Related collections

          Author and article information

          Journal
          N Engl J Med
          The New England journal of medicine
          Massachusetts Medical Society
          1533-4406
          0028-4793
          Aug 08 2002
          : 347
          : 6
          Affiliations
          [1 ] Département d'Hématologie et d'Oncologie, Hôpital de Hautepierre, Strasbourg, France. raoul.herbrecht@chru-strasbourg.fr
          Article
          347/6/408
          10.1056/NEJMoa020191
          12167683
          05b117e0-5202-4d31-8f6c-e93c0a7763c5
          Copyright 2002 Massachusetts Medical Society
          History

          Comments

          Comment on this article